Contact
Please use this form to send email to PR contact of this press release:
EMINENT supports Multiple Groundbreaking Studies Exploring the Role of Semaglutide and Tirzepatide in Clinical Trials
TO:
Sam Mullapudi
EMINENT Services Corporation
+1 240-422-4164